Skip to main content
Premium Trial:

Request an Annual Quote

Lundbeck to Use Cogenics' Genotyping Platform in Phase I Trials

NEW YORK (GenomeWeb News) – Cogenics said today that it will provide the Danish pharmaceutical company H. Lundbeck with genotyping services to support clinical drug studies.
 
Under the agreement, the Clinical Data subsidiary will conduct genotyping in its labs in Morrisville, NC, and in Bernried, Germany, for Lundbeck’s Phase I clinical trials. Cogenics said the period of the agreement is open-ended and that the companies plan to collaborate on other projects in the future.
 
Lundbeck is focused on developing and marketing drugs for treating psychiatric and neurological disorders.
 
Financial terms of the agreement were not released.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.